Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1231395.RAa6OJ9PVYftOdRV-0BPqhaIxGfL0aluGxqdm17FAOGDc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1231395.RAa6OJ9PVYftOdRV-0BPqhaIxGfL0aluGxqdm17FAOGDc130_assertion type Assertion NP1231395.RAa6OJ9PVYftOdRV-0BPqhaIxGfL0aluGxqdm17FAOGDc130_head.
- NP1231395.RAa6OJ9PVYftOdRV-0BPqhaIxGfL0aluGxqdm17FAOGDc130_assertion description "[Matched primary and metastatic tumor lesions from clinical specimens revealed similar MUC1 IHC labeling patterns, and a tissue microarray of human PDA biopsies revealed increased immunolabeling with a combination of MUC1 and mesothelin (MSLN) antibodies, compared with either antibody alone.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1231395.RAa6OJ9PVYftOdRV-0BPqhaIxGfL0aluGxqdm17FAOGDc130_provenance.
- NP1231395.RAa6OJ9PVYftOdRV-0BPqhaIxGfL0aluGxqdm17FAOGDc130_assertion evidence source_evidence_literature NP1231395.RAa6OJ9PVYftOdRV-0BPqhaIxGfL0aluGxqdm17FAOGDc130_provenance.
- NP1231395.RAa6OJ9PVYftOdRV-0BPqhaIxGfL0aluGxqdm17FAOGDc130_assertion SIO_000772 25336517 NP1231395.RAa6OJ9PVYftOdRV-0BPqhaIxGfL0aluGxqdm17FAOGDc130_provenance.
- NP1231395.RAa6OJ9PVYftOdRV-0BPqhaIxGfL0aluGxqdm17FAOGDc130_assertion wasDerivedFrom befree-2016 NP1231395.RAa6OJ9PVYftOdRV-0BPqhaIxGfL0aluGxqdm17FAOGDc130_provenance.
- NP1231395.RAa6OJ9PVYftOdRV-0BPqhaIxGfL0aluGxqdm17FAOGDc130_assertion wasGeneratedBy ECO_0000203 NP1231395.RAa6OJ9PVYftOdRV-0BPqhaIxGfL0aluGxqdm17FAOGDc130_provenance.